Lane Generational LLC Invests $1.44 Million in STAAR Surgical (NASDAQ:STAA)

Lane Generational LLC purchased a new position in shares of STAAR Surgical (NASDAQ:STAA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 59,336 shares of the medical instruments supplier's stock, valued at approximately $1,441,000. STAAR Surgical accounts for about 1.4% of Lane Generational LLC's portfolio, making the stock its 21st largest position. Lane Generational LLC owned approximately 0.12% of STAAR Surgical as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also added to or reduced their stakes in STAA. Quarry LP bought a new position in STAAR Surgical in the 3rd quarter valued at approximately $50,000. Quest Partners LLC bought a new position in shares of STAAR Surgical during the third quarter valued at $128,000. Van ECK Associates Corp raised its stake in shares of STAAR Surgical by 12.7% during the third quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier's stock valued at $129,000 after acquiring an additional 393 shares during the last quarter. Larson Financial Group LLC raised its stake in shares of STAAR Surgical by 78.3% during the third quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier's stock valued at $181,000 after acquiring an additional 2,135 shares during the last quarter. Finally, Creative Planning raised its stake in shares of STAAR Surgical by 8.0% during the third quarter. Creative Planning now owns 5,524 shares of the medical instruments supplier's stock valued at $205,000 after acquiring an additional 408 shares during the last quarter. Institutional investors own 96.70% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on STAA shares. Stifel Nicolaus decreased their price objective on shares of STAAR Surgical from $38.00 to $20.00 and set a "buy" rating for the company in a research report on Wednesday, February 12th. Mizuho cut shares of STAAR Surgical from an "outperform" rating to a "neutral" rating and decreased their price objective for the stock from $45.00 to $17.00 in a research report on Wednesday, February 12th. Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a research report on Thursday, February 27th. Canaccord Genuity Group decreased their price objective on shares of STAAR Surgical from $28.00 to $17.00 and set a "hold" rating for the company in a research report on Thursday, February 13th. Finally, StockNews.com cut shares of STAAR Surgical from a "hold" rating to a "sell" rating in a research report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $26.86.

Remove Ads

Insider Activity

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. acquired 23,000 shares of STAAR Surgical stock in a transaction dated Wednesday, December 18th. The stock was purchased at an average cost of $24.33 per share, for a total transaction of $559,590.00. Following the completion of the acquisition, the insider now directly owns 10,848,631 shares of the company's stock, valued at $263,947,192.23. This represents a 0.21 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders acquired 910,843 shares of company stock worth $15,509,972 over the last three months. 1.00% of the stock is currently owned by insiders.

STAAR Surgical Price Performance

Shares of NASDAQ STAA opened at $18.34 on Wednesday. The stock has a market capitalization of $904.62 million, a P/E ratio of -44.73 and a beta of 0.66. The company has a 50-day moving average price of $20.81 and a 200-day moving average price of $26.44. STAAR Surgical has a 1 year low of $13.50 and a 1 year high of $52.68.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.